PTSD memory eraser trial for teens pulled before it began
NCT ID NCT04921982
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aimed to see if the blood pressure drug propranolol could reduce PTSD symptoms in adolescents by blocking the reconsolidation of traumatic memories. Participants would have taken propranolol or a placebo before briefly recalling their trauma, once a week for six weeks. However, the trial was withdrawn before enrolling any teens, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Propranolol
What this could lead to
If it had worked, this could have pointed toward a new way to treat PTSD in teens by weakening traumatic memories.
What could go wrong
The trial was withdrawn before any participants were enrolled, so no results are available. Even if it had run, it was a small early-phase study, and propranolol's effect on memory is still uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Louis Mourier
Colombes, France
-
CH Bohars
Bohars, France
-
CH Guillaume Régnier
Rennes, 35000, France
-
CH Le Havre
Le Havre, France
-
CHU Angers
Angers, France
-
CHU Besançon
Besançon, France
-
CHU Limoges
Limoges, France
-
CHU Nantes
Nantes, France
-
CHU Poitiers
Poitiers, France
-
CHU Rouen
Rouen, France